Research Progress in the Application of Immune Checkpoint Inhibitors for Renal Cell Carcinoma
Bibliographic record
Abstract
In recent years, immune checkpoint inhibitors (ICIs) have made significant progress in the treatment of renal cell carcinoma (RCC). Especially, the PD-1, PD-L1, and CTLA-4 inhibitors have significantly improved the therapeutic efficacy and prognosis of some patients with kidney cancer. This article reviews the research progress and representative drugs of ICIs in the treatment of RCC, such as nivolumab, pembrolizumab, and Ipilimumab, and analyzes their therapeutic advantages and combination treatment strategies. At the same time, this article also points out that there are still challenges such as heterogeneity of therapeutic efficacy, drug resistance, toxic side effects, and difficulties in evaluating therapeutic efficacy (such as pseudoprogression and hyperprogression). To improve treatment effectiveness, future research should focus on precise population screening, biomarker development, combined therapy, and new nanoscale drug development. In conclusion, although ICIs show great potential in the treatment of RCC, their broad application still requires more mechanism exploration and support from individualized treatment strategies.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.001 |
| Science and technology studies | 0.000 | 0.003 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".